Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies

Craig Hansen, Susan E. Andrade, Heather Freiman, Sascha Dublin, Katie Haffenreffer, William O. Cooper, T. Craig Cheetham, Sengwee Toh, De-Kun Li, Marsha A. Raebel,

Pharmacoepidemiology and Drug Safety · 2015 · 35 citations · 29 references

Abstract

First-trimester TMP-SUL exposure was not associated with a higher risk of the congenital anomalies studied, compared with exposure to penicillins and/or cephalosporins, or no exposure to antibacterials.

References

29